Related Experiment Video
Updated: Jul 6, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Protease-activated receptor-1 mediates thrombin-induced persistent sodium current in human cardiomyocytes
Caroline Pinet1, Vincent Algalarrondo, Sylvie Sablayrolles
1Centre National de la Recherche Scientifique, Unité 8162, Université de Paris XI, and Laboratoire de Recherches Médicales, Hôpital Marie Lannelongue, Le Plessis-Robinson, France.
Insights
Thrombin activates protease-activated receptor-1 (PAR1) in the heart, increasing sodium current and action potential duration. This finding reveals a novel mechanism contributing to cardiac ischemia injury.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
Background:
- Thrombin, a serine protease, forms after cardiac thrombus and can reach myocardial tissue.
- Protease-activated receptor-1 (PAR1) is expressed in human myocardium and binds thrombin.
- The role of PAR1 in thrombin's effect on cardiac sodium current (I(Na)) requires investigation.
Purpose of the Study:
- To investigate the role of PAR1 in thrombin-induced alterations of sodium current (I(Na)).
- To determine the signaling pathways involved in PAR1 activation by thrombin.
- To assess the impact of PAR1-mediated I(Na) changes on cardiac action potentials.
Main Methods:
- Whole-cell patch-clamp technique to record I(Na) in human atrial myocytes.
- Conventional glass microelectrode technique for action potential (AP) recording in guinea pig ventricular tissue.
- Pharmacological manipulation using PAR1 agonists, antagonists, and phospholipase-A(2) inhibitors.
Main Results:
- Thrombin-activated PAR1 induced a tetrodotoxin-sensitive persistent sodium current (I(NaP)) in a concentration-dependent manner.
- PAR1 agonist SFLLR-NH(2) mimicked thrombin's action, while antagonists SCH 203099 and ER 112787 inhibited I(NaP).
- Inhibition of calcium-independent phospholipase-A(2) blocked PAR1-thrombin-induced I(NaP).
- I(NaP) activation significantly increased action potential duration (APD) in guinea pig ventricular muscle.
- Increased APD was prevented by tetrodotoxin and reduced by PAR1 antagonists.
Conclusions:
- Thrombin, via PAR1 activation, enhances the persistent sodium current (I(NaP)) in cardiomyocytes.
- This uncontrolled sodium influx contributes to cellular injuries during cardiac ischemia.
- The calcium-independent phospholipase-A(2) pathway is involved in PAR1-mediated I(NaP) regulation.
Abstract:
After the thrombus formation in cardiac cavities or coronaries, the serine protease thrombin is produced and can therefore reach the myocardial tissue by the active process of extravasation and binds to the G protein-coupled protease-activated receptor-1 (PAR1) expressed in human myocardium. The role of PAR1 was investigated in the thrombin effect on sodium current (I(Na)). I(Na) was recorded in freshly isolated human atrial myocytes by the whole-cell patch-clamp method. Action potentials (AP) were recorded in guinea pig ventricular tissue by the conventional glass microelectrode technique. Thrombin-activated PAR1 induced a tetrodotoxin-blocked persistent sodium current, I(NaP), in a concentration-dependent manner with an apparent EC(50) of 28 U/ml. The PAR1 agonist peptide SFLLR-NH(2) (50 microM) was able to mimic PAR1-thrombin action, whereas PAR1 antagonists N(3)-cyclopropyl-7-((4-(1-methylethyl)-phenyl)methyl)-7H-pyrrolo(3,2-f)quinazoline-1,3-diamine (SCH 203099; 10 microM) and 1-(3,5-di-tert-butyl-4-hydroxy-phenyl)-2-[3-(3-ethyl-3-hydroxy-pentyl)-2-imino-2,3-dihydro-imidazol-1-yl]-ethanone (ER 112787) (1 microM), completely inhibited it. The activated PAR1 involves the calcium-independent phospholipase-A(2) signaling pathway because two inhibitors of this cascade, bromoenol lactone (50 microM) and haloenol lactone suicide substrate (50 microM), block PAR1-thrombin-induced I(NaP).Asa consequence of I(NaP) activation, in guinea pig right ventricle papillary muscle, action potential duration (APD) were significantly increased by 20% and 15% under the respective action of 32 U/ml thrombin and 50 microM SFLLR-NH(2), and these increases in APD were prevented by 1 microM tetrodotoxin or markedly reduced by application of 1 microM SCH 203099 or ER 112787. Thrombin, through PAR1 activation, increases persistent component of the Na(+) current resulting in an uncontrolled sodium influx into the cardiomyocyte, which can contribute to cellular injuries observed during cardiac ischemia.
More Related Videos
07:13Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
08:56Demonstration of Proteolytic Activation of the Epithelial Sodium Channel (ENaC) by Combining Current Measurements with Detection of Cleavage Fragments
Published on: July 5, 2014
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
G-Protein Gated Ion Channels
Sensory organs,...
Intracellular Signaling Affects Focal Adhesions
Some...
Mechanically-gated Ion Channels